Vapor-Based Endoscopic Ablation Therapy
Total Trials
8
As Lead Sponsor
As Collaborator
0
Total Enrollment
186
NCT04578353
Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients
Phase: N/A
Role: Lead Sponsor
Start: Jan 28, 2020
Completion: Jun 12, 2022
NCT05843201
AquaPass Device in Treatment of CHF Patients
Start: Feb 20, 2022
Completion: Dec 12, 2023
NCT06358365
Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients
Start: Mar 29, 2023
Completion: Nov 7, 2023
NCT05887635
Study of Duodenal Mucosal RF Vapor Ablation in Subjects With Type-2 Diabetes Mellitus
Start: Sep 2, 2023
Completion: Jun 30, 2026
NCT06360380
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
Start: Sep 5, 2024
Completion: Jan 29, 2025
NCT06655740
Safety, Tolerability, and Effectiveness of Duodenal Mucosal RF Vapor Ablation for Insulin Elimination in Type-2 Diabetes
Start: Oct 1, 2024
Completion: Jul 31, 2025
NCT06724822
RF Vapor Ablation Retreatment of Duodenal Mucosa in Non-responders With Type-2 Diabetes Mellitus
Start: Nov 14, 2024
Completion: Oct 31, 2025
NCT06401109
Naturally Controlled Decongestion Using Renal Independent System in ADHF Patients, a European Registry
Start: Feb 28, 2025
Completion: May 31, 2026
Loading map...